An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
NCT00826514
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions
DRUG:
Tanezumab
DRUG:
Placebo
Sponsor
Pfizer